All News

This eBook will focus on the specific needs and concerns of the smaller to mid-size biopharmaceutical company. Articles cover considerations from Phase II to commercial pathways.

Is report worth a look as potential springboard to addressing future EU ties in healthcare-or just more bluster?

How STEM helps women advance from lab bench to boardroom.

Amid political and economic turmoil in recent years, and resulting shortcomings in healthcare budget, medical infrastructure, and drug access, the Ukraine government is championing the introduction of an unprecedented set of reforms, prompting a significant evolution in the country's healthcare system.

Click the title above to open the Pharmaceutical Executive September 2017 issue in an interactive PDF format.

Click the title above to open the Pharmaceutical Executive August 2017 issue in an interactive PDF format.

If it feels like the media’s scrutiny of pharma has intensified recently, there's a reason-it has, as the results of our 13th Annual Press Audit indicate.

As digital technologies transform drug development and marketing, a retooled medical affairs function can be a competitive differentiator.